Abstract The food enzyme cellulase (4‐(1,3; 1,4)‐β‐d‐glucan‐4‐glucanohydrolase, EC 3.2.1.4) is produced with the genetically modified Trichoderma reesei strain NZYM‐FS by Novozymes A/S. The genetic modifications did not give rise to safety concerns. The food enzyme was considered free from viable cells of the production organism and its DNA.
EFSA Panel on Food Enzymes (FEZ) +20 more
wiley +1 more source
Anticoagulation Monitoring in Recurrent Venous Thromboembolism Associated With Antiphospholipid Antibodies and Subsequent Heparin-Induced Thrombocytopenia. [PDF]
Bechir G.
europepmc +1 more source
Abstract The food enzyme endo‐polygalacturonase (1,4‐α‐D‐galacturonan glycanohydrolase, EC 3.2.1.15) is produced with the non‐genetically modified Rhizopus oryzae strain MC3‐3‐9 by Shin Nihon Chemical Co., Ltd. The food enzyme was considered free from viable cells of the production organism.
EFSA Panel on Food Enzymes (FEZ) +19 more
wiley +1 more source
When A Fall Isn't Just a Fall: Delayed Diagnosis of Acquired Hemophilia A in a Nonagenarian Patient. [PDF]
Gobhil S, Khunger A, Kandoth Karerat P.
europepmc +1 more source
Factors Associated With Discordance Between the Activated Partial Thromboplastin Time and Anti-factor Xa Activity During Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study. [PDF]
Simms B, Carmona C, Karam O.
europepmc +1 more source
Severe Acquired Factor VIII Deficiency With Concomitant Lupus Anticoagulant: A Case Report. [PDF]
Kim TH, Khawar A, Suh J.
europepmc +1 more source
A shorter aPTT during acute psychological stress does not necessarily indicate contact pathway activation. [PDF]
Wang Z, Huang Y.
europepmc +1 more source
Acquired hemophilia a caused by complicated urinary tract infection due to flavobacterium odoratum: A case report and literature review. [PDF]
Chen D, Yuan P, Ren M.
europepmc +1 more source
Never Say Never: Presumed Inherited Factor VII Deficiency Lies in Wait for 17 Years. [PDF]
Runde AP +4 more
europepmc +1 more source
Development and validation of a deep learning model to predict heparin response in critically ill patients with deep vein thrombosis receiving continuous intravenous heparin infusion. [PDF]
Liu S +9 more
europepmc +1 more source

